Next Generation News and Research

RSS

Surviving without glucose: uridine-derived ribose as an alternative energy source

Researchers attempted to identify new genes and molecular pathways that might supply energy when the availability of glucose or other nutrients is limited.

22 May 2023

Study reports improved deliverability, tracking, and deployment of next-generation Evolut FX TAVR system

Results from the Evolut FX TAVR (Transcatheter Aortic Valve Replacement) Clinical Survey were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses.

19 May 2023

Efficient assay system aids rapid genetic diagnosis of mitochondrial diseases

The gene ECHS1 encodes for enoyl-CoA hydratase short-chain 1, a mitochondrial enzyme involved in branched-chain amino acid and fatty acid metabolism.

18 May 2023

Study examines safety and efficacy of made-to-fade tattoos for medical markings

Researchers at Henry Ford Health - one of the nation's leading integrated academic medical institutions - in collaboration with Ephemeral Tattoo, have conducted a study on the safety and efficacy of made-to-fade tattoos for medical markings.

17 May 2023

Novel computational platform can expand the pool of cancer immunotherapy targets

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.

17 May 2023

Bioresorbable vascular scaffolds may be just as effective as drug-eluting metal stents for treating heart disease patients

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

17 May 2023

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

As part of the Foundation for the National Institutes of Health Accelerating Medicines Partnership Bespoke Gene Therapy Consortium, Nemours Children's Health has been chosen to conduct a first-of-its-kind gene therapy clinical trial for Morquio A syndrome.

16 May 2023

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

A collaborative agreement between Izon Science and Agarose Bead Technologies (ABT) offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

From Agarose Bead Technologies 16 May 2023

Henry Ford Health cardiologists perform new coronary bypass procedure that replicates an old operation

Henry Ford Health Interventional cardiologists William O'Neill, M.D., and Khaldoon Alaswad, M.D., took a page out of the medical history books by performing a new coronary bypass procedure replicated from one not used in decades to treat a patient living with crippling angina - a severe symptom of coronary artery disease.

15 May 2023

Newly identified biomarker may predict NSCLC patients' treatment response to chemoimmunotherapy

Cutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with more common approaches such as chemotherapy. But determining the best treatment combination isn't always straightforward.

12 May 2023

Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecoviruses

Researchers longitudinally isolated immensely potent monoclonal antibodies from macaques vaccinated with COVID-19.

12 May 2023

Most nurses claim insufficient staffing as the leading cause of their well-being struggles

Cross Country Healthcare, Inc., a market-leading, tech-enabled workforce solutions platform and advisory firm, in collaboration with Florida Atlantic University, today announced the results of its annual survey of nursing professionals and students.

11 May 2023

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

11 May 2023

Mount Sinai researchers identify a new therapeutic target for MS and other brain disorders

Cross-talk between brain cells and peripheral immune cells can modulate the progression of multiple sclerosis (MS), Mount Sinai researchers have discovered.

8 May 2023

Clinicians must broaden their duty of care while treating people with deep-seated trauma

Child protection experts are imploring clinicians to broaden their duty of care to ensure that patients’ hidden trauma is not overlooked by more obvious physical symptoms and illnesses.

8 May 2023

Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

Researchers described a new method to safely release DNA from ancient tooth and bone artifacts.

5 May 2023

Global Access Diagnostics (GADx) welcomes new leadership

GADx announces today that Mr Mark Davis is stepping down as CEO and co-founder after 20 years of unwavering service, having created the organisation Mologic Ltd in June 2003 alongside his father and industry leader, Prof. Paul Davis.

From Global Access Diagnostics 5 May 2023

Exploring the World of RNA Chemistry

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Philip Bevilacqua from Pennsylvania State University about the world of RNA chemistry.

From Pittcon 5 May 2023

Scientists to lead a $15 million project to study how chronic stress can increase cardiovascular risk

Teams of research scientists from three universities will lead an innovative $15 million project to study the biological mechanisms of chronic stress that can increase cardiovascular disease risk.

4 May 2023

Next Generation News and Research

Surviving without glucose: uridine-derived ribose as an alternative energy source

Study reports improved deliverability, tracking, and deployment of next-generation Evolut FX TAVR system

Novel gene-editing strategy harnesses an unusual protective ability to eliminate HIV-1 infection

Efficient assay system aids rapid genetic diagnosis of mitochondrial diseases

Study examines safety and efficacy of made-to-fade tattoos for medical markings

Novel computational platform can expand the pool of cancer immunotherapy targets

Bioresorbable vascular scaffolds may be just as effective as drug-eluting metal stents for treating heart disease patients

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

Next-Generation EV Separation: Izon Science and Agarose Bead Technologies Collaborate to Enhance Clinical Applications for Extracellular Vesicles

Henry Ford Health cardiologists perform new coronary bypass procedure that replicates an old operation

Newly identified biomarker may predict NSCLC patients' treatment response to chemoimmunotherapy

Study identifies extremely potent monoclonal antibodies that neutralized multiple sarbecoviruses

Most nurses claim insufficient staffing as the leading cause of their well-being struggles

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Mount Sinai researchers identify a new therapeutic target for MS and other brain disorders

Clinicians must broaden their duty of care while treating people with deep-seated trauma

Study describes a novel, non-destructive method to extract DNA from ancient bone and tooth artifacts

Global Access Diagnostics (GADx) welcomes new leadership

Exploring the World of RNA Chemistry

Scientists to lead a $15 million project to study how chronic stress can increase cardiovascular risk

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News